Clinical Trial Update: Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice

View source ↗

Summary

This completed trial update evaluated tolerability and real-world treatment outcomes of Nebido (testosterone undecanoate) in men with hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Nebido (testosterone undecanoate)

Snippet

Sponsor: Bayer | Conditions: Male, Hypogonadism | Status: COMPLETED